Ryan Solomon - Enhabit Chief Officer
| EHAB Stock | USD 7.66 0.01 0.13% |
Executive
Ryan Solomon is Chief Officer of Enhabit
| Address | 6688 N. Central Expressway, Dallas, TX, United States, 75206 |
| Phone | 214 239 6500 |
| Web | https://www.ehab.com |
Enhabit Management Efficiency
The company has return on total asset (ROA) of 0.0177 % which means that it generated a profit of $0.0177 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1746) %, meaning that it created substantial loss on money invested by shareholders. Enhabit's management efficiency ratios could be used to measure how well Enhabit manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.26. The current year's Return On Capital Employed is expected to grow to -0.03. At present, Enhabit's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 218.1 M, whereas Total Assets are forecasted to decline to about 1.3 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Matthew Ruderman | Definitive Healthcare Corp | N/A | |
| Jennifer JD | Doximity | 56 | |
| Matthew Robinson | Veeva Systems Class | 50 | |
| Jacques Mourrain | Veeva Systems Class | N/A | |
| Andrew Dahl | Edwards Lifesciences Corp | 47 | |
| Mark MS | Outset Medical | 67 | |
| Joel Davis | Doximity | N/A | |
| Jason Raser | Venus Concept | N/A | |
| Brian Wagener | Veeva Systems Class | 42 | |
| Steven Williamson | Outset Medical | 51 | |
| Carrie Lazorchak | Definitive Healthcare Corp | 54 | |
| Gary Sorsher | Edwards Lifesciences Corp | 59 | |
| John Brottem | Outset Medical | 49 | |
| Michael Mandarello | Venus Concept | 38 | |
| Daniel Lippis | Edwards Lifesciences Corp | 48 | |
| Arnold Pinkston | Edwards Lifesciences Corp | 65 | |
| Christine McCauley | Edwards Lifesciences Corp | 59 | |
| Anat Kotler | Venus Concept | 40 | |
| Jennifer Chaloemtiarana | Doximity | 56 | |
| William McGrail | Venus Concept | 63 | |
| Richard CPA | Definitive Healthcare Corp | 55 | |
Management Performance
| Return On Equity | -0.17 | ||||
| Return On Asset | 0.0177 |
Enhabit Leadership Team
Elected by the shareholders, the Enhabit's board of directors comprises two types of representatives: Enhabit inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enhabit. The board's role is to monitor Enhabit's management team and ensure that shareholders' interests are well served. Enhabit's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enhabit's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Brewer, Chief Officer | ||
| Dylan Black, General Secretary | ||
| RN BSN, Executive Operations | ||
| Tanya Marion, Chief Officer | ||
| PT MBA, Ex Strategy | ||
| Ryan Solomon, Chief Officer | ||
| Langham MBA, Executive Strategy | ||
| Dan Peoples, Ex Marketing | ||
| BS MA, CEO Pres | ||
| Crissy Carlisle, Chief Officer |
Enhabit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Enhabit a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.17 | ||||
| Return On Asset | 0.0177 | ||||
| Profit Margin | (0.11) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 919.97 M | ||||
| Shares Outstanding | 50.28 M | ||||
| Shares Owned By Insiders | 2.88 % | ||||
| Shares Owned By Institutions | 97.12 % | ||||
| Number Of Shares Shorted | 1.21 M | ||||
| Price To Earning | 6.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Enhabit offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enhabit's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enhabit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enhabit Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enhabit. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Enhabit Stock refer to our How to Trade Enhabit Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enhabit. If investors know Enhabit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enhabit listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.92) | Earnings Share (2.33) | Revenue Per Share 20.661 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0177 |
The market value of Enhabit is measured differently than its book value, which is the value of Enhabit that is recorded on the company's balance sheet. Investors also form their own opinion of Enhabit's value that differs from its market value or its book value, called intrinsic value, which is Enhabit's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enhabit's market value can be influenced by many factors that don't directly affect Enhabit's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enhabit's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enhabit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enhabit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.